Yoshino Shigefumi

Affiliate Master Yamaguchi University

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)

BMC cancer Volume 12 Issue 1 Page 307-

published_at 2012-07-23

Title

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)

Creators Tsuburaya Akira

Creators Morita Satoshi

Creators Kodera Yasuhiro

Creators Kobayashi Michiya

Creators Shitara Kohei

Creators Yamaguchi Kensei

Creators Yoshikawa Takaki

Creators Yoshida Kazuhiro

Creators Yoshino Shigefumi

Creators Sakamoto Jun-ichi

Creator Keywords

Biomarker Capecitabine Cisplatin Clinical trial Gastric cancer S-1

Languages eng

Resource Type journal article

Publishers BioMed Central

Date Issued 2012-07-23

File Version Not Applicable (or Unknown)

Access Rights metadata only access

Relations

[ISSN]1471-2407

[NCID]AA12034763

[PMID]info:pmid/22824079

info:doi/10.1186/1471-2407-12-307

[isVersionOf] [URI]http://www.biomedcentral.com/bmccancer/archive/

Schools 医学部附属病院